Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior - PubMed (original) (raw)

Comparative Study

. 2004 Jun;29(6):1190-202.

doi: 10.1038/sj.npp.1300420.

Allegra Broft, Richard W Foltin, Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, Audrey Perez, W Gordon Frankle, Thomas Cooper, Herbert D Kleber, Marian W Fischman, Marc Laruelle

Affiliations

• PMID: 15010698
• DOI: 10.1038/sj.npp.1300420

Comparative Study

Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior

Diana Martinez et al. Neuropsychopharmacology. 2004 Jun.

Erratum in

• Neuropsychopharmacology. 2004 Sep;29(9):1763. Frankel, W Gordon [corrected to Frankle, W Gordon]

Abstract

Striatal dopamine D2 receptors have been implicated in the neurobiology of cocaine addiction. Previous imaging studies showed reduced striatal D2 receptor availability in chronic cocaine abusers, and animal studies suggested that low D2 receptor availability promotes cocaine self-administration. Here, D2 receptor availability was assessed with positron emission tomography (PET) and [11C]raclopride in the limbic, associative, and sensori-motor subdivisions of the striatum in 17 recently detoxified chronic cocaine-dependent (CCD) subjects and 17 matched healthy control (HC) subjects. In addition, the relationship between regional D2 receptor availability and behavioral measures obtained in cocaine self-administration sessions was investigated in CCD subjects. [11C]Raclopride binding potential was significantly reduced by 15.2% in the limbic striatum, 15.0% in the associative striatum, and 17.1% in the sensori-motor striatum in CCD subjects compared to HC subjects. In CCD subjects, no relationship was detected between D2 availability in striatal regions and either the positive effects of smoked cocaine or the choice of cocaine over an alternative reinforcer (money) following a priming dose of cocaine (a laboratory model of relapse). Thus, this study confirms previous reports of a modest decrease in D2 receptor availability in CCD subjects, and establishes that this decrease is generalized throughout the striatum. However, this study failed to demonstrate a relationship between D2 receptor availability and cocaine-induced cocaine-taking behavior. Additional research is warranted to unravel potential neurobiological traits that might confer vulnerability to relapse in detoxified CCD subjects.

Copyright 2004 Nature Publishing Group

PubMed Disclaimer

Similar articles

• Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
  Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M. Martinez D, et al. J Cereb Blood Flow Metab. 2003 Mar;23(3):285-300. doi: 10.1097/01.WCB.0000048520.34839.1A. J Cereb Blood Flow Metab. 2003. PMID: 12621304
• Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.
  Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Volkow ND, et al. J Neurosci. 2006 Jun 14;26(24):6583-8. doi: 10.1523/JNEUROSCI.1544-06.2006. J Neurosci. 2006. PMID: 16775146 Free PMC article.
• Socioeconomic status is associated with striatal dopamine D2/D3 receptors in healthy volunteers but not in cocaine abusers.
  Wiers CE, Shokri-Kojori E, Cabrera E, Cunningham S, Wong C, Tomasi D, Wang GJ, Volkow ND. Wiers CE, et al. Neurosci Lett. 2016 Mar 23;617:27-31. doi: 10.1016/j.neulet.2016.01.056. Epub 2016 Jan 29. Neurosci Lett. 2016. PMID: 26828302 Free PMC article.
• PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation.
  Nader MA, Czoty PW. Nader MA, et al. Am J Psychiatry. 2005 Aug;162(8):1473-82. doi: 10.1176/appi.ajp.162.8.1473. Am J Psychiatry. 2005. PMID: 16055768 Review.
• Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
  Ashok AH, Mizuno Y, Volkow ND, Howes OD. Ashok AH, et al. JAMA Psychiatry. 2017 May 1;74(5):511-519. doi: 10.1001/jamapsychiatry.2017.0135. JAMA Psychiatry. 2017. PMID: 28297025 Free PMC article. Review.

Cited by

• Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.
  Belujon P, Jakobowski NL, Dollish HK, Grace AA. Belujon P, et al. Neuropsychopharmacology. 2016 Jan;41(2):619-27. doi: 10.1038/npp.2015.191. Epub 2015 Jul 1. Neuropsychopharmacology. 2016. PMID: 26129677 Free PMC article.
• Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence.
  Trifilieff P, Martinez D. Trifilieff P, et al. Front Psychiatry. 2013 Jun 3;4:44. doi: 10.3389/fpsyt.2013.00044. eCollection 2013. Front Psychiatry. 2013. PMID: 23760592 Free PMC article.
• Increased vulnerability to cocaine in mice lacking dopamine D3 receptors.
  Song R, Zhang HY, Li X, Bi GH, Gardner EL, Xi ZX. Song R, et al. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17675-80. doi: 10.1073/pnas.1205297109. Epub 2012 Oct 8. Proc Natl Acad Sci U S A. 2012. PMID: 23045656 Free PMC article.
• Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation.
  Trifilieff P, Feng B, Urizar E, Winiger V, Ward RD, Taylor KM, Martinez D, Moore H, Balsam PD, Simpson EH, Javitch JA. Trifilieff P, et al. Mol Psychiatry. 2013 Sep;18(9):1025-33. doi: 10.1038/mp.2013.57. Epub 2013 May 28. Mol Psychiatry. 2013. PMID: 23711983 Free PMC article.
• A potential link between gambling addiction severity and central dopamine levels: Evidence from spontaneous eye blink rates.
  Mathar D, Wiehler A, Chakroun K, Goltz D, Peters J. Mathar D, et al. Sci Rep. 2018 Sep 6;8(1):13371. doi: 10.1038/s41598-018-31531-1. Sci Rep. 2018. PMID: 30190487 Free PMC article.

Publication types

MeSH terms

Substances

Grants and funding

• 2-R01-DA10219-01/DA/NIDA NIH HHS/United States
• K08 DA00483-01/DA/NIDA NIH HHS/United States
• M01RR00645/RR/NCRR NIH HHS/United States
• PA50 DA 09236-06/DA/NIDA NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information